Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma : KEYNOTE-240
dc.contributor.author | Ryoo, B. Y. | |
dc.contributor.author | Merle, P. | |
dc.contributor.author | Kulkarni, A. S. | |
dc.contributor.author | Cheng, A. L. | |
dc.contributor.author | Bouattour, M. | |
dc.contributor.author | Lim, H. Y. | |
dc.contributor.author | Breder, V. | |
dc.contributor.author | Edeline, J. | |
dc.contributor.author | Chao, Y. | |
dc.contributor.author | Garrido S., Marcelo | |
dc.contributor.author | Ogasawara, S. | |
dc.contributor.author | Yau, T. | |
dc.contributor.author | Chan, S. L. | |
dc.contributor.author | Daniele, B. | |
dc.contributor.author | Norquist, J. M. | |
dc.contributor.author | Chen, E. | |
dc.contributor.author | Siegel, A. B. | |
dc.contributor.author | Zhu, A. X. | |
dc.contributor.author | Finn, R. S. | |
dc.contributor.author | Kudo, M. | |
dc.date.accessioned | 2021-06-29T19:45:34Z | |
dc.date.available | 2021-06-29T19:45:34Z | |
dc.date.issued | 2021 | |
dc.fechaingreso.objetodigital | 2024-10-17 | |
dc.format.extent | 10 páginas | |
dc.fuente.origen | Converis | |
dc.identifier.doi | 10.1002/cncr.33317 | |
dc.identifier.eissn | 1097-0142 | |
dc.identifier.issn | 0008-543X | |
dc.identifier.scopusid | 2-s2.0-85096702993 | |
dc.identifier.uri | https://doi.org/10.1002/cncr.33317 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/60960 | |
dc.identifier.wosid | WOS:000591767000001 | |
dc.information.autoruc | Escuela de Medicina ; Garrido S., Marcelo ; 0000-0001-8905-8986 ; 7260 | |
dc.issue.numero | No. 6 | |
dc.language.iso | en | |
dc.nota.acceso | Contenido completo | |
dc.pagina.final | 874 | |
dc.pagina.inicio | 865 | |
dc.revista | Cancer | es_ES |
dc.rights | acceso abierto | |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.subject.ods | 03 Good health and well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.subject.other | Carcinoma Hepatocelular - Terapia | es_ES |
dc.subject.other | Neoplasias hepáticas | es_ES |
dc.subject.other | Calidad de vida | es_ES |
dc.title | Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma : KEYNOTE-240 | es_ES |
dc.type | artículo | |
dc.volumen | Vol. 127 | |
sipa.codpersvinculados | 7260 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Health-related quality-of-life impact of pembrolizumab versus best supportive care.pdf
- Size:
- 384.39 KB
- Format:
- Adobe Portable Document Format
- Description: